BiomX
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BiomX and other ETFs, options, and stocks.About PHGE
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively.
CEOJonathan Eithan Solomon
CEOJonathan Eithan Solomon
Employees57
Employees57
HeadquartersNess Ziona, Tel Aviv
HeadquartersNess Ziona, Tel Aviv
Founded2015
Founded2015
Employees57
Employees57
PHGE Key Statistics
Market cap7.17M
Market cap7.17M
Price-Earnings ratio-0.16
Price-Earnings ratio-0.16
Dividend yield—
Dividend yield—
Average volume69.09K
Average volume69.09K
High today$4.81
High today$4.81
Low today$4.48
Low today$4.48
Open price$4.81
Open price$4.81
Volume26.93K
Volume26.93K
52 Week high$22.06
52 Week high$22.06
52 Week low$4.10
52 Week low$4.10
Stock Snapshot
As of today, BiomX(PHGE) shares are valued at $4.77. The company's market cap stands at 7.17M, with a P/E ratio of -0.16.
As of 2025-12-04, BiomX(PHGE) stock has fluctuated between $4.48 and $4.81. The current price stands at $4.77, placing the stock +6.6% above today's low and -0.8% off the high.
BiomX(PHGE) shares are trading with a volume of 26.93K, against a daily average of 69.09K.
During the past year, BiomX(PHGE) stock moved between $4.10 at its lowest and $22.06 at its peak.
During the past year, BiomX(PHGE) stock moved between $4.10 at its lowest and $22.06 at its peak.
People also own
Based on the portfolios of people who own PHGE. This list is generated using Robinhood data, and it’s not a recommendation.